Realnova Healthcare

FEATURES OF Iron Sucrose Injection USP:

• Composition: Each ml typically contains Iron Sucrose equivalent to elemental iron (usually 20 mg/ml).

• Appearance: Dark brown, sterile aqueous solution.

• Therapeutic Category: Hematinic (used for iron replacement therapy).

• Indication:

  • Treatment of iron deficiency anemia in patients with chronic kidney disease (CKD).

  • Suitable for patients who are intolerant to oral iron therapy or where oral therapy is ineffective.

• Mechanism of Action:

  • Provides bioavailable iron which is incorporated into hemoglobin and other iron-containing enzymes.

  • Restores iron stores and corrects anemia.

• Advantages:

  • Rapid correction of iron deficiency.

  • Better gastrointestinal tolerability compared to oral iron.

  • Lower risk of severe allergic reactions compared to older parenteral iron preparations (like iron dextran).

  • Can be administered during dialysis sessions.

• Route of Administration: Intravenous injection or infusion.

• Dosage Form: Available in ampoules or vials (commonly 100 mg/5 ml).

• Storage: Store below 25°C; protect from light and freezing.

• Safety Profile: Generally well-tolerated; minimal risk of anaphylaxis when administered correctly.

FEATURES OF TRANEXAMIC ACID INJECTION:

1. Active Ingredient: Tranexamic Acid – an antifibrinolytic agent.

2. Mechanism of Action: Prevents excessive bleeding by inhibiting the breakdown of fibrin clots (antifibrinolytic effect).

3. Indications:

   • Control and prevention of excessive bleeding in surgery, trauma, or obstetric conditions.

   • Management of menorrhagia (heavy menstrual bleeding).

   • Treatment of bleeding associated with dental procedures in hemophilic patients.

4. Dosage Form: Sterile solution for intravenous (IV) or intramuscular (IM) injection.

5. Typical Strengths: 500 mg/5 mL or 100 mg/mL ampoules/vials.

6. Onset of Action: Rapid, with hemostatic effect typically observed soon after administration.

7. Pharmacological Class: Antifibrinolytic / Hemostatic agent.

8. Benefits:

   • Reduces surgical blood loss.

   • Decreases need for blood transfusion.

   • Effective in various bleeding disorders.

9. Storage: Store below 25°C, protect from light, do not freeze.

10. Packaging: Usually supplied in glass ampoules or vials, sterile and pyrogen-free.

FEATURES

• Contains Cyproheptadine Hydrochloride & Tricholine Citrate

• Acts as an appetite stimulant

• Helps in weight gain for underweight individuals

• Supports liver function and improves digestion

• Useful in loss of appetite, anorexia, and undernutrition

• May help in allergic conditions due to Cyproheptadine’s antihistaminic action

FEATURES OF Telmisartan & Amlodipine Tablets IP

• Dual-action antihypertensive combination – Telmisartan (an ARB) + Amlodipine (a calcium channel blocker) work together to control high blood pressure.

• Effective blood pressure control – Reduces both systolic and diastolic blood pressure.

• Vasodilation effect – Amlodipine relaxes blood vessels; Telmisartan blocks angiotensin II, preventing vessel narrowing.

• Reduces cardiovascular risk – Helps lower the risk of heart attack, stroke, and other heart-related complications.

• Kidney protective benefits – Particularly useful in patients with hypertension and diabetes.

• Once-daily dosing – Convenient for better patient compliance (depending on strength prescribed).

• Long-lasting action – Provides 24-hour blood pressure control.

• Well-tolerated combination – Suitable for long-term management of hypertension.

• Helps in edema control – Telmisartan helps counteract fluid retention sometimes caused by amlodipine alone.

• Used in – Mild to severe hypertension, especially when monotherapy is insufficient.

FEATURES OF
Amlodipine & Atenolol Tablets I.P.

• Dual-action antihypertensive combination: Amlodipine (calcium channel blocker) + Atenolol (beta-blocker) for better blood pressure control

• Treats hypertension (high blood pressure) effectively

• Helps in management of angina pectoris (chest pain)

• Reduces heart workload by slowing heart rate (Atenolol)

• Improves blood flow by relaxing blood vessels (Amlodipine)

• Provides sustained 24-hour BP control with once-daily dosing

• Prevents cardiovascular complications such as stroke and heart attack

• Well-tolerated formulation with minimal side effects when used as prescribed

• Suitable for patients not controlled by monotherapy

• Convenient fixed-dose combination for better compliance